Tepmongkol et al., 2008) was reported in a phase II clinical trial that on the other hand concluded a not complete response of patients (Kebebew et al., 2009)
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial One randomized, double-blind, placebo-controlled trial evaluated the safety and effectiveness of oral semaglutide (GLP-1) 50 mg, taken once daily in adults with overweight or obesity who did not have type 2 diabetes
However, a noticeable effect on weight loss and fat burning will probably take several days to several weeks, depending on the metabolism, age, health, and lifestyle
10.1371/journal.pone.0039953 15 BidoS.SoriaF
While GLP-1 medications can offer significant results for many men, theyre not the best fit for everyone